This is a preview of subscription content, log in via an institution to check access.
Reference
Saverio Mennini F, et al. Cost-effectiveness analysis of Vaborem in Carbapenem-resistant Enterobacterales (CRE) -Klebsiella pneumoniae infections in Italy Health Economics Review : 30 Oct 2021. Available from: URL: https://doi.org/10.1186/s13561-021-00341-z
Rights and permissions
About this article
Cite this article
Meropenem/vaborbactam cost effective in Italy. PharmacoEcon Outcomes News 891, 17 (2021). https://doi.org/10.1007/s40274-021-08175-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-08175-8